Issue 1716
Cover Stories
Public Sector
Covered Bonds
Financial Institutions
Bond Comments
Securitization
Corporate Bonds
Syndicated Loans and Leveraged Finance
Emerging Markets
Equity
Market News
People Moves
-
BiVictriX Therapeutics plc, an emerging biotechnology company that develops new cancer therapies, began trading on London's alternative investment market (Aim) on Wednesday following its IPO.